Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
The transaction, which was completed in June 2025, secures the benefits of over 3,500 members of the scheme
CMI_2024 produces cohort life expectancies at age 65 that are about three months higher for males and about two weeks higher for females than in the previous version of the CMI model.
The total value of all three deals is £900m.
The deal secures the pensions of around 500 plan members.
The portfolio comprised approximately 70 life insurance policies with an aggregate face value of more than $500m.
ClearLife will be adding to its suite of software and consulting services for longevity-risk market participants, including reverse mortgages and structured settlements.
Transaction covers two schemes worth £63m and £4m.
The estimated retiree pension risk transfer cost is now 101.1% of a plan’s accumulated benefit obligation.
The report, which covers the period 2024/2025, analyses data received from market leaders across 13 countries internationally across Europe, North America and Australia with established or developing equity release markets and explores their growth potential.
Sixth straight quarter where sales pass $100bn.